E-cadherin-integrin crosstalk in cancer invasion and metastasis
about
Regulation of Endothelial Adherens Junctions by Tyrosine PhosphorylationThe role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cellsIGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy ResistanceLevels of soluble E-cadherin in breast, gastric, and colorectal cancersFAK in cancer: mechanistic findings and clinical applicationsRAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expressionSurrounding tissues canalize motile cardiopharyngeal progenitors towards collective polarity and directed migration.Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionRegulation of epithelial-mesenchymal transition through epigenetic and post-translational modificationsThe Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinomaPFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric CancerElevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas.PAR-3 knockdown enhances adhesion rate of PANC-1 cells via increased expression of integrinαv and E-cadherin.What is known about melatonin, chemotherapy and altered gene expression in breast cancerOverexpression of N-cadherin and β-catenin correlates with poor prognosis in patients with nasopharyngeal carcinoma.Regulation of Desmocollin3 Expression by Promoter Hypermethylation is Associated with Advanced Esophageal Adenocarcinomas.ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression.Identification of Ras suppressor-1 (RSU-1) as a potential breast cancer metastasis biomarker using a three-dimensional in vitro approach.ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expressionNUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.Breast cancer cell adhesome and degradome interact to drive metastasisCorrelation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme.E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.FRAS1 knockdown reduces A549 cells migration and invasion through downregulation of FAK signaling.High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic processBioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerBuformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cellsTumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancerRUNX3 site-specific hypermethylation predicts papillary thyroid cancer recurrence.Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.STK33 overexpression in hypopharyngeal squamous cell carcinoma: possible role in tumorigenesisWnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively.Classifying ten types of major cancers based on reverse phase protein array profiles.Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR ActivityBoth mTORC1 and mTORC2 are involved in the regulation of cell adhesion.HOTAIR is a therapeutic target in glioblastoma.The Roles of MicroRNAs in Breast CancerGene signature model for breast cancer risk prediction for women with sclerosing adenosis.BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma.Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling
P2860
Q26778080-38695A23-14FE-49C5-9B43-46FD962A57CBQ26796377-7F807A00-E5A0-4E93-AE7A-26A00C5629B4Q26802042-02BB41DB-F6DB-4E13-9175-9F11AD09EA40Q27012638-87102FCB-CCB8-425F-AC6D-531FAE77913EQ27026533-4044F75D-2F7C-4D55-88EE-8D539BAD44BDQ27320277-5F94EA7B-27F4-4908-8835-E14CD4CA1458Q27346342-889952DF-4267-4D40-A7C2-DB3F73CF60B8Q28066285-4C67C6BB-4389-4DB6-B8FD-F2CC93B4661EQ28076697-97050316-554D-4E3B-8E2D-80070DA66B0DQ28540190-8997F6A7-27E2-4AE7-BF29-7EFFCDA5D542Q28554349-1F9995CF-3542-49FA-B2B5-06F92F29F01EQ30655673-8EFDA357-32BE-4652-9E9B-A001B633A082Q31157379-1BE8660B-35A8-4035-B7A1-0AEB2BFB3220Q33597963-409E9A7D-230F-4522-96EC-BE1C4FC1A26DQ33598104-CC8E6310-7A6F-4C5B-9B93-8672680D6368Q33634990-5CF58E1C-4E2C-4D90-A448-929F0EFF25FCQ33671316-EB87B07F-B5FD-499E-A0C8-7B583A32AA00Q33689045-A98B800F-3302-421F-B0E1-B54AAAC7BF77Q33800620-34B5B685-A97C-402B-96EC-B1830BB4657FQ33823188-6CF2019F-B147-41FC-95BD-75B1018CFAE6Q33914711-F150EFEC-46A2-403B-A0EC-44429FC4A25FQ33945781-2C0EEEF2-F676-4E94-B248-B40471A410EEQ34037623-C6BCC4BD-2EDC-494B-84CA-F5FD9AC89B13Q34042181-1BC28EA6-B7E9-4128-B857-349BAC8E955CQ34100951-09546A1B-EB00-4A9A-8331-D06121E1448EQ34295621-6E21F661-E764-450E-A7F8-0F6F53A95281Q34533709-6ACC2A02-256B-4D24-AD48-2A86A6E79968Q34657698-A5E15DF7-F333-43CF-A786-C234F4462659Q34704862-48B67061-05E1-4BD2-AE06-5E2553A723B0Q34978807-01E49B83-CFB5-4B8D-832E-6B4B4483BAD8Q35008698-B224BC54-038F-4907-9773-B04B57FF180EQ35549371-F5B1D57A-3DE6-4E15-AB7B-01FFAD77A52AQ35590038-212B0A03-AD48-479C-968D-2E67EC06FF38Q35633988-0BF2BA81-BF9D-41B8-9047-6C502B264B35Q35740165-31AA0AC9-D781-47DB-8CCE-BA57F8EC3615Q35781595-BFECDA05-22B8-4E8E-A7C8-58CAC92B352AQ35818407-62FFA427-0AAE-4903-9BD4-1A328AA621D2Q35901647-49ED532E-10D2-47B3-8B8A-1F7BB4912CEAQ35924344-2927CF1A-B7EC-43FC-AB5D-004CFF9D67F4Q35933347-C08AF5AA-EE19-4EEB-927A-9615A3438612
P2860
E-cadherin-integrin crosstalk in cancer invasion and metastasis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@ast
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@en
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@nl
type
label
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@ast
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@en
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@nl
prefLabel
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@ast
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@en
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@nl
P2093
P3181
P356
P1476
E-cadherin-integrin crosstalk in cancer invasion and metastasis
@en
P2093
Alan Serrels
Marta Canel
Valerie G Brunton
P304
P3181
P356
10.1242/JCS.100115
P407
P577
2013-01-01T00:00:00Z